“Specialty Trend”

14 result(s)
Cost Management
Our job at CVS Caremark is to be the best manager of our clients’ pharmacy spend, which includes better engaging patients and their providers throughout the duration of therapy,... More
Feature
Specialty
Specialty drug trend remains a critical challenge for clients across the CVS Caremark pharmacy benefit management book of business. Careful management strategies are key to... More
Briefing
A couple stroll together on the beach
Cost Management
In 2019, drug trend for CVS Caremark pharmacy benefit clients was a historically low, industry-leading 1.4 percent, with 41% of clients seeing negative trend. Specialty trend was... More
Feature
Care Management
Payors can better manage oncology costs by optimizing therapy regimen selection using evidence-based guidelines directly integrated into our proprietary Novologix platform. More
Video
Specialty
CVS Health uses its integrated model to manage specialty spend across benefits and help positively impact clinical and financial outcomes. More
Briefing
Person On Laptop
Specialty
Specialty spend continues to grow rapidly; CVS Health continues to innovate with strategies that reduced the trend impact of inflation significantly, to 1.7 percent. More
Video
Father and son
Cost Management
As a health care innovation company, our steadfast focus is on helping to reduce costs and improve outcomes for our pharmacy benefit management (PBM) clients and their plan... More
Feature
Lady in high street
Cost Management
We want clients and members to get the most out of their benefit and the cost of a drug is aligned with the value it delivers. Despite AWP inflation near 10%, we kept drug price... More
Feature
Two hands rolling cookie dough
Cost Management
Transform RA Care is a comprehensive solution that combines high-touch care with strategic cost management to deliver a pharmacy trend guarantee and better patient outcomes. More
Feature
Pills and female pharmacist icon
Specialty
The impact of specialty medications on payors’ trend is not only rising, it is doing so more rapidly than ever before. From 2010 to 2015, spending on specialty drugs doubled,... More
Feature